Shares of Max Healthcare Institute Limited experienced a decline of 1.77% to trade at Rs 1,160.30 in Tuesday's session, amidst high volume. The stock is a constituent of the Nifty Midcap 150 index.
Financial Snapshot:
Here's a look at the consolidated financial performance of Max Healthcare Institute Limited:
Consolidated Quarterly Performance:
Heading | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
---|---|---|---|---|---|
Revenue | Rs 1,542.95 Crore | Rs 1,707.46 Crore | Rs 1,868.31 Crore | Rs 1,909.74 Crore | Rs 2,027.57 Crore |
Net Profit | Rs 236.27 Crore | Rs 281.81 Crore | Rs 238.80 Crore | Rs 319.00 Crore | Rs 307.97 Crore |
EPS | 2.43 | 2.90 | 2.46 | 3.28 | 3.17 |
The company's revenue has shown consistent growth over the quarters. Revenue increased from Rs 1,542.95 Crore in June 2024 to Rs 2,027.57 Crore in June 2025. Net profit also saw fluctuations but remained generally strong, with a peak of Rs 319.00 Crore in March 2025. The EPS has mirrored this trend, with the highest value of Rs 3.28 in March 2025.
Consolidated Yearly Performance:
Heading | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|
Revenue | Rs 2,504.67 Crore | Rs 3,931.46 Crore | Rs 4,562.60 Crore | Rs 5,406.02 Crore | Rs 7,028.46 Crore |
Net Profit | -114.50 Crore | 605.05 Crore | 1,103.51 Crore | 1,057.64 Crore | 1,075.88 Crore |
EPS | -1.59 | 6.25 | 11.38 | 10.89 | 11.07 |
BVPS | 58.37 | 64.79 | 76.31 | 86.51 | 96.50 |
ROE | -2.43 | 9.63 | 14.89 | 12.57 | 11.46 |
Debt to Equity | 0.16 | 0.12 | 0.08 | 0.14 | 0.27 |
The yearly data reveals a strong turnaround from a net loss in 2021 to consistent profits in subsequent years. Revenue has also grown substantially year-over-year. In 2025, the revenue increased by 29.99% compared to 2024. The debt-to-equity ratio has increased from 0.14 in 2024 to 0.27 in 2025.
Consolidated Yearly Income Statement:
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | |
---|---|---|---|---|---|
Sales | Rs 7,028 Crore | Rs 5,406 Crore | Rs 4,562 Crore | Rs 3,931 Crore | Rs 2,504 Crore |
Other Income | Rs 155 Crore | Rs 178 Crore | Rs 139 Crore | Rs 127 Crore | Rs 114 Crore |
Total Income | Rs 7,184 Crore | Rs 5,584 Crore | Rs 4,701 Crore | Rs 4,058 Crore | Rs 2,619 Crore |
Total Expenditure | Rs 5,612 Crore | Rs 4,158 Crore | Rs 3,554 Crore | Rs 3,219 Crore | Rs 2,508 Crore |
EBIT | Rs 1,571 Crore | Rs 1,425 Crore | Rs 1,147 Crore | Rs 839 Crore | Rs 110 Crore |
Interest | Rs 165 Crore | Rs 59 Crore | Rs 83 Crore | Rs 100 Crore | Rs 179 Crore |
Tax | Rs 330 Crore | Rs 307 Crore | Rs -39 Crore | Rs 133 Crore | Rs 45 Crore |
Net Profit | Rs 1,075 Crore | Rs 1,057 Crore | Rs 1,103 Crore | Rs 605 Crore | Rs -114 Crore |
The consolidated yearly income statement shows consistent growth in sales and total income. Total expenditure has also increased, but the company has maintained strong earnings before interest and taxes (EBIT). Net profit has improved significantly since 2021.
Consolidated Quarterly Income Statement:
Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | |
---|---|---|---|---|---|
Sales | Rs 2,027 Crore | Rs 1,909 Crore | Rs 1,868 Crore | Rs 1,707 Crore | Rs 1,542 Crore |
Other Income | Rs 36 Crore | Rs 46 Crore | Rs 33 Crore | Rs 40 Crore | Rs 34 Crore |
Total Income | Rs 2,064 Crore | Rs 1,956 Crore | Rs 1,901 Crore | Rs 1,748 Crore | Rs 1,577 Crore |
Total Expenditure | Rs 1,608 Crore | Rs 1,498 Crore | Rs 1,540 Crore | Rs 1,341 Crore | Rs 1,232 Crore |
EBIT | Rs 455 Crore | Rs 457 Crore | Rs 361 Crore | Rs 407 Crore | Rs 345 Crore |
Interest | Rs 54 Crore | Rs 55 Crore | Rs 52 Crore | Rs 33 Crore | Rs 23 Crore |
Tax | Rs 92 Crore | Rs 83 Crore | Rs 70 Crore | Rs 91 Crore | Rs 85 Crore |
Net Profit | Rs 307 Crore | Rs 319 Crore | Rs 238 Crore | Rs 281 Crore | Rs 236 Crore |
The consolidated quarterly income statement demonstrates consistent growth in sales and total income. Total expenditure has also increased, but the company has maintained strong earnings before interest and taxes (EBIT). Net profit has remained strong over the quarters.
Consolidated Cash Flow:
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | |
---|---|---|---|---|---|
Operating Activities | Rs 1,459 Crore | Rs 1,121 Crore | Rs 1,209 Crore | Rs 748 Crore | Rs 117 Crore |
Investing Activities | Rs -1,631 Crore | Rs -1,285 Crore | Rs -1,187 Crore | Rs -771 Crore | Rs -73 Crore |
Financing Activities | Rs -163 Crore | Rs -263 Crore | Rs -288 Crore | Rs -294 Crore | Rs 191 Crore |
Others | Rs 17 Crore | Rs 32 Crore | Rs 0 Crore | Rs 0 Crore | Rs 279 Crore |
Net Cash Flow | Rs -318 Crore | Rs -394 Crore | Rs -266 Crore | Rs -317 Crore | Rs 515 Crore |
The cash flow statement shows positive cash flow from operating activities but negative cash flow from investing and financing activities in recent years.
Consolidated Balance Sheet:
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | |
---|---|---|---|---|---|
Share Capital | Rs 972 Crore | Rs 971 Crore | Rs 970 Crore | Rs 969 Crore | Rs 965 Crore |
Reserves & Surplus | Rs 8,408 Crore | Rs 7,368 Crore | Rs 6,397 Crore | Rs 5,290 Crore | Rs 4,646 Crore |
Current Liabilities | Rs 1,813 Crore | Rs 1,248 Crore | Rs 1,045 Crore | Rs 757 Crore | Rs 776 Crore |
Other Liabilities | Rs 4,019 Crore | Rs 2,410 Crore | Rs 1,688 Crore | Rs 2,171 Crore | Rs 2,155 Crore |
Total Liabilities | Rs 15,214 Crore | Rs 11,999 Crore | Rs 10,101 Crore | Rs 9,189 Crore | Rs 8,544 Crore |
Fixed Assets | Rs 8,922 Crore | Rs 6,384 Crore | Rs 4,836 Crore | Rs 4,714 Crore | Rs 4,108 Crore |
Current Assets | Rs 1,592 Crore | Rs 1,706 Crore | Rs 1,943 Crore | Rs 1,000 Crore | Rs 1,124 Crore |
Other Assets | Rs 4,699 Crore | Rs 3,909 Crore | Rs 3,322 Crore | Rs 3,474 Crore | Rs 3,311 Crore |
Total Assets | Rs 15,214 Crore | Rs 11,999 Crore | Rs 10,101 Crore | Rs 9,189 Crore | Rs 8,544 Crore |
Contingent Liabilities | Rs 1,374 Crore | Rs 1,169 Crore | Rs 326 Crore | Rs 515 Crore | Rs 388 Crore |
The balance sheet shows consistent growth in total assets and liabilities over the years. Reserves and surplus have also increased, reflecting the company's profitability. Fixed assets have increased from Rs 6,384 Crore in 2024 to Rs 8,922 Crore in 2025.
Financial Ratios:
Ratio | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Basic EPS (Rs.) | 11.07 | 10.89 | 11.38 | 6.25 | -1.59 |
Diluted EPS (Rs.) | 11.01 | 10.84 | 11.36 | 6.24 | -1.59 |
Book Value / Share (Rs.) | 96.50 | 86.51 | 76.31 | 64.79 | 58.37 |
Dividend / Share (Rs.) | 1.50 | 1.50 | 0.00 | 0.00 | 0.00 |
Face Value | 10 | 10 | 10 | 10 | 10 |
Gross Profit Margin (%) | 28.51 | 30.89 | 30.24 | 27.21 | 20.70 |
Operating Margin (%) | 23.40 | 26.36 | 25.15 | 21.58 | 13.75 |
Net Profit Margin (%) | 15.30 | 19.56 | 24.18 | 15.38 | -4.57 |
Return on Equity (%) | 11.46 | 12.57 | 14.89 | 9.63 | -2.43 |
ROCE (%) | 12.27 | 13.25 | 12.67 | 10.06 | 4.43 |
Return On Assets (%) | 7.07 | 8.81 | 10.92 | 6.58 | -1.60 |
Current Ratio (X) | 0.88 | 1.37 | 1.86 | 1.32 | 1.45 |
Quick Ratio (X) | 0.82 | 1.30 | 1.79 | 1.24 | 1.38 |
Debt to Equity (x) | 0.27 | 0.14 | 0.08 | 0.12 | 0.16 |
Interest Coverage Ratios (X) | 12.15 | 27.89 | 16.45 | 10.61 | 1.92 |
Asset Turnover Ratio (%) | 0.52 | 0.49 | 0.22 | 0.22 | 29.31 |
Inventory Turnover Ratio (X) | 74.28 | 0.00 | 0.00 | 0.00 | 46.56 |
3 Yr CAGR Sales (%) | 33.71 | 46.91 | 107.56 | 6,170.14 | 4,904.67 |
3 Yr CAGR Net Profit (%) | 33.35 | 203.92 | 824.54 | 2,359.78 | 970.05 |
P/E (x) | 99.09 | 75.29 | 38.76 | 55.62 | -129.40 |
P/B (x) | 11.37 | 9.48 | 5.78 | 5.35 | 3.53 |
EV/EBITDA (x) | 54.09 | 47.77 | 30.38 | 31.65 | 38.85 |
P/S (x) | 15.17 | 14.75 | 9.38 | 8.56 | 7.95 |
Key financial ratios for Max Healthcare Institute Limited show a P/E ratio of 99.09 and a P/B ratio of 11.37. The company reported a debt-to-equity ratio of 0.27 as of the year-ending March 2025.
The company announced a final dividend of Rs 1.50 per share on May 20, 2025, with an effective date of July 4, 2025. Another final dividend of Rs 1.50 per share was announced on May 22, 2024, with an effective date of August 23, 2024.
Moneycontrol analysis, as of August 28, 2025, suggests a very bearish sentiment on the stock.
The stock's last traded price was Rs 1,160.30, and Moneycontrol analysis suggests a very bearish sentiment.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!